Nuzenio

Context Therapeutics Reports

Context Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Context Therapeutics price target lowered to $3 from $4 at Citizens - TipRanksTipRanks · Thu, 06 Aug 2026 23:15:10 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - TradingViewTradingView · Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - Stock TitanStock Titan · Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics reports Q2 EPS (15c), consensus (9c) - TipRanksTipRanks · Thu, 06 Aug 2026 00:40:34 GMTContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:44:29 GMTContext Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:14:11 GMTContext Therapeutics Inc. 1H 2026: Net income $(23.24)M, Diluted EPS $(0.24) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:11:00 GMTContext Therapeutics (NASDAQ: CNTX) reports $23.2 million loss and cash runway - Stock TitanStock Titan · Wed, 05 Aug 2026 20:10:38 GMT

Timeline

Thu, 06 Aug 2026 23:15:10 GMTContext Therapeutics price target lowered to $3 from $4 at Citizens - TipRanks
Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - TradingView
Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - Stock Titan
Thu, 06 Aug 2026 00:40:34 GMTContext Therapeutics reports Q2 EPS (15c), consensus (9c) - TipRanks
Wed, 05 Aug 2026 21:44:29 GMTContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 20:14:11 GMTContext Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress - GlobeNewswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Context Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.